TELUS HEALTH (UK) HOLDCO LTD.Active

Company number 09976204Private limited companyIncorporated 2016

Key figures

£123,384,000+20.8%
Net assets 2024
+29.2%
Average annual growth 2020–2024
050 m100 m150 m20202021202220232024

TELUS HEALTH (UK) HOLDCO LTD. does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2024
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 m100 m150 m20202021202220232024

Dividends

from the accounts
2021

Dividends paid in the financial year: £17,000,000 (100% of the profit for the year).

History
2021£17,000,000
2020101,436,000 ARS
Filed accounts2020–2024
20202021202220232024
Profit for the year017,000,00016,932,000171,000-24,000
Total assets—————
Total liabilities2,612,0003,918,00021,914,00021,391,000163,000
Net assets / total equity44,231,00032,533,00063,218,000102,156,000123,384,000
Average number of employees3,0003,0003,0003,0002,000
Dividends paid-101,436,000-17,000,000———

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: TELUS HEALTH (UK) HOLDCO LTD.

Company

TELUS HEALTH (UK) HOLDCO LTD. is a private limited company registered with Companies House under company number 09976204. It was incorporated on 28 Jan 2016. Its status is active. The registered office is in London (W1B). Its nature of business (SIC 2007) is human resources provision and management of human resources functions (78300).

Accounts

The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files full accounts. Loss for the year was £24,000. Net assets were £123,384,000, up 20.8% on the previous year. The company had an average of 2,000 employees. Figures are available for 5 financial years (2020–2024).

Control and charges

The company has 2 current directors.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 10 Feb 2027.